Diagnostic and prognostic value of miR-205 in colorectal cancer

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 9, 2014, Pages 4033-4037

  Orang, Ayla Valinezhad ^a   Safaralizadeh, Reza ^a   Feizi, Mohammad Ali Hosseinpour ^a   Somi, Mohammad Hossein ^b  

^a UNIVERSITY OF TABRIZ   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biomarker; Colorectal cancer; Metastasis; microRNA; miR 205

Indexed keywords

MICRORNA; MIRN205 MICRORNA, HUMAN; TUMOR MARKER;

AGED; BIOSYNTHESIS; COLORECTAL NEOPLASMS; DISEASE COURSE; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IRAN; LYMPH NODE METASTASIS; MALE; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC;

AGED; BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IRAN; LYMPHATIC METASTASIS; MALE; MICRORNAS; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE;

EID: 84902675151     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.9.4033     Document Type: Article

References (29)

1. Ahmed FE, Jeffries CD, Vos PW, et al (2009). Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue. Cancer Genomics Proteomics, 6, 281-95.
2. Azimzadeh P, Romani S, Mohebbi SR, et al (2012). Association of polymorphisms in microRNA-binding sites and colorectal cancer in an Iranian population. Cancer Genet, 205, 501-7.
3. Bandres E, Agirre X, Bitarte N (2009). Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer, 125, 2737-43.
4. Barsky SH, Siegal GP, Jannotta F, Liotta LA (1983). Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest, 49, 140-7.
5. Bonfrate L, Altomare DF, Di Lena M (2013). MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment. J Gastrointestin Liver Dis, 22, 311-20.
6. Darnell DK, Kaur S, Stanislaw S, et al (2006). MicroRNA expression during chick embryo development. Dev Dyn, 235, 3156-65.
7. Greene SB, Gunaratne PH, Hammond SM, Rosen JM (2010a). A putative role for microRNA-205 in mammary epithelial cell progenitors. J Cell Sci, 123, 606-18.
8. Greene SB, Herschkowitz JI, Rosen JM (2010b). The ups and downs of miR-205: identifying the roles of miR-205 in mammary gland development and breast cancer. RNA Biol, 7, 300-4.
9. Gregory PA, Bert AG, Paterson EL, et al (2008a). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol, 10, 593-601.
10. Gregory PA, Bracken CP, Bert AG, Goodall GJ (2008b). MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle, 7, 3112-8.
11. Haghighi MM, Javadi GR, Parivar K (2010). Frequent MSI mononucleotide markers for diagnosis of hereditary nonpolyposis colorectal cancer. Asian Pac J Cancer Prev, 11, 1033-5.
12. Henry NL, Hayes DF (2012). Cancer biomarkers. Mol Oncol, 6, 140-6.
13. Iorio MV, Croce CM (2009). MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol, 27, 5848-56.
14. Janbabai G, Farazmandfar T, Khosravi S (2013). An investigation on 10 micro RNAs in colorectal cancer as biomarkers to predict disease progression. Adv Biolog Res, 7, 144-9.
15. Lim J, Thiery JP (2012). Epithelial-mesenchymal transitions: insights from development. Development, 139, 3471-86.
16. Orang AV, Safaralizadeh R, Hosseinpour Feizi MA (2014). Insights into the diverse roles of miR-205 in human cancers. Asian Pac J Cancer Prev, 15, 577-83.
17. Poste G (2011). Bring on the biomarkers. Nature, 469, 156-7.
18. Poste G, Carbone DP, Parkinson DR, et al (2012). Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug development. Clin Cancer Res, 18, 1515-23.
19. Pourhoseingholi MA (2012). Increased burden of colorectal cancer in Asia. World J Gastrointest Oncol, 4, 68-70.
20. Qin AY, Zhang XW, Liu L, et al (2013). MiR-205 in cancer: an angel or a devil? Eur J Cell Biol, 92, 54-60.
21. Salimzadeh H, Delavari A, Montazeri A, Mirzazadeh A (2012). Knowledge and practice of iranians toward colorectal cancer, and barriers to screening. Int J Prev Med, 3, 29-35.
22. Savad S, Mehdipour P, Miryounesi M, et al (2012). Expression analysis of MiR-21, MiR-205, and MiR-342 in breast cancer in Iran. Asian Pac J Cancer Prev, 13, 873-7.
23. Shemirani AI, Haghighi MM, Zadeh SM (2011). Simplified MSI marker panel for diagnosis of colorectal cancer. Asian Pac J Cancer Prev, 12, 2101-4.
24. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.
25. Sordat I, Rousselle P, Chaubert P, et al (2000). Tumor cell budding and laminin-5 expression in colorectal carcinoma can be modulated by the tissue micro-environment. Int J Cancer, 88, 708-17.
26. Spaderna S, Schmalhofer O, Hlubek F, et al (2006). A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology, 131, 830-40.
27. Tellez CS, Juri DE, Do K, et al (2011). EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. Cancer Res, 71, 3087-97.
28. Thiery JP, Sleeman JP (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol, 7, 131-42.
29. Zhao BS, Liu SG, Wang TY, et al (2012). Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. Asian Pac J Cancer Prev, 13, 139-43.